Education
About Us
Working with TipRanks
Follow Us
Ventas (DE:VEN)
FRANKFURT:VEN
VEN Stock Chart & Stats
€60.10
€0.54(0.99%)
At close: 4:00 PM EST
€60.10
€0.54(0.99%)
Day’s Range― - ―
52-Week Range€53.08 - €66.76
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$28.21B
Enterprise Value€42.05B
Total Cash (Recent Filing)$614.20M
Total Debt (Recent Filing)$13.27B
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Oct 29, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding454,471,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)2.25
Price to Sales (P/S)4.92
P/FCF Ratio33.41
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue7.93
Enterprise Value/Gross Profit21.89
Enterprise Value/Ebitda20.93
Forecast
1Y Price Target
$65.69Price Target Upside9.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
Acquisitions And InvestmentsVTR closed $1.8bn in senior housing investments YTD, with FY25 investment volume expected at $2.0 billion.
Occupancy RatesSHOP same store average occupancy increased by ~270 bps YoY in August QTD, suggesting continued selling season momentum.
Revenue GrowthVTR reaffirmed ~8% SHOP SS revenue growth for FY25.
Bears Say
Ventas News
VEN FAQ
What was Ventas’s price range in the past 12 months?
Ventas lowest stock price was €53.08 and its highest was €66.76 in the past 12 months.
What is Ventas’s market cap?
Ventas’s market cap is $28.21B.
When is Ventas’s upcoming earnings report date?
Ventas’s upcoming earnings report date is Oct 29, 2025 which is in 3 days.
How were Ventas’s earnings last quarter?
Ventas released its earnings results on Jul 30, 2025. The company reported €0.129 earnings per share for the quarter, beating the consensus estimate of €0.116 by €0.013.
Is Ventas overvalued?
According to Wall Street analysts Ventas’s price is currently Undervalued.
Does Ventas pay dividends?
Ventas does not currently pay dividends.
What is Ventas’s EPS estimate?
Ventas’s EPS estimate is 0.08.
How many shares outstanding does Ventas have?
Ventas has 454,471,200 shares outstanding.
What happened to Ventas’s price movement after its last earnings report?
Ventas reported an EPS of €0.129 in its last earnings report, beating expectations of €0.116. Following the earnings report the stock price went up 0.416%.
Which hedge fund is a major shareholder of Ventas?
Currently, no hedge funds are holding shares in DE:VEN
Ventas Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.69 (9.31% Upside)
$65.69 (9.31% Upside)
Blogger Sentiment
Bullish
DE:VEN Sentiment 83%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.89%
12-Months-Change
Fundamentals
Return on Equity
1.81%
Trailing 12-Months
Asset Growth
7.93%
Trailing 12-Months
Company Description
Ventas
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
VEN Company Deck
VEN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant growth in SHOP and outpatient medical segments, alongside an increase in investment guidance. However, challenges remain with the headwinds from post-acute asset dispositions and a competitive acquisition market. Overall, the call presents a positive outlook with some caution regarding specific segments.View all DE:VEN earnings summariesVEN Revenue Breakdown
68.49% SHOP
17.82% OM&R
12.63% NNN
1.05% Non-Segment
VEN Stock 12 Month Forecast
Average Price Target
€65.69
▲(9.31% Upside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―
Options Prices
Currently, No data available
---